Expert US stock credit rating analysis and default risk assessment to identify financial distress signals. We monitor credit markets to understand the health of companies and potential risks to equity holders.
As of 2026-04-13, The Beauty Health Company (SKIN) trades at a current price of $0.88, marking a 1.54% decline from the previous session’s close. This analysis evaluates key technical levels, recent sector context, and potential short-term price scenarios for SKIN, with no company-specific material news driving price action in recent sessions. No recent earnings data is available for the company at the time of writing, so near-term price movements are primarily tied to technical trading patterns
Is The Beauty (SKIN) Stock in a Selling Zone | Price at $0.88, Down 1.54% - Analyst Upgrade
SKIN - Stock Analysis
3205 Comments
1485 Likes
1
Gwin
Legendary User
2 hours ago
That’s next-level wizard energy. 🧙
👍 121
Reply
2
Cherisha
Insight Reader
5 hours ago
Truly a benchmark for others.
👍 276
Reply
3
Larodney
Senior Contributor
1 day ago
Who else is thinking the same thing right now?
👍 33
Reply
4
Alexender
Active Reader
1 day ago
Could’ve done something earlier…
👍 227
Reply
5
Novie
Influential Reader
2 days ago
Expert US stock credit rating analysis and default risk assessment to identify financial distress signals. We monitor credit markets to understand the health of companies and potential risks to equity holders.
👍 144
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.